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Abstract: Voltammetric behaviors of six nitro-substituted benzamides, which are potential prodrug candidates for
nitroreductase-based cancer therapy, were investigated using cyclic voltammetry (CV) and diﬀerential pulse voltammetry
(DPV). The electrochemical behavior of aromatic nitro (ArNO 2 ) compounds by CV indicates that compounds involve
various reduction/oxidation steps including the formation of aromatic nitro radical, nitroso, hydroxylamine, and amine
groups. Applicability of the voltammetric determination of these prodrug candidates was studied by recording their
DPVs, carried out in mixed media (Britton Robinson buﬀer solution + DMF) at various pH values on a pencil graphite
electrode (PGE). Results show that the PGE can oﬀer a disposable, low-cost, and sensitive electrochemical determination
method for identifying nitro benzamide compounds. Under the experimental conditions, the PGE had a linear response
range from 0.5 to 100 µ M 4-nitro- N -(2-nitrophenyl)benzamide (compound 2). This voltammetric procedure indicates
that nitro-substituted benzamide drugs can be successfully determined in pharmaceutical samples.
Key words: Voltammetry, pencil graphite electrode, nitro-substituted benzamide compounds

1. Introduction
Nitro aromatic compounds (ArNO 2 ) have received considerable attention over recent decades as they are widely
used as pesticides, explosives, pharmaceuticals, and chemical intermediates in industry due to their important
functions such as pollutants and toxicants, in mutagenesis and carcinogenesis, and for their therapeutic actions. 1
Some of these compounds are potently toxic or carcinogenic, presenting a considerable danger to the human
population, and are widely distributed environmental pollutants found in industrial regions. On the other hand,
it is well known that many ArNO 2 compounds are widely used as prodrugs or drugs (e.g., chloramphenicol, 2 5(aziridine-1-yl)-2,4-dinitrobenzamide (CB1954), 3,4 nilutamide, 5 flutamide, 6 nimesulide, 7,8 ledakrin and derivatives of 1-nitro-9-aminoacridine 9,10 and niclosamide, 11 nitracrine, nitrazepam, nitrofurantoin, nitromersol, nitromide, and dinodeb 12 ). These compounds have antihelminthic, antiprotozoal, and antibacterial properties
that aid in combating a variety of protozoan and bacterial infections, as well as antitumor and anticancer,
anticonvulsant, and antiinflammatory activities. Therefore, many researchers have focused on the synthesis and
biological or therapeutic activity of new ArNO 2 compounds for these reasons. 13−21
∗ Correspondence:
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The therapeutic and biological activity mechanism of ArNO 2 compounds can be explained by their electrochemical behavior since the reduction of ArNO 2 compounds, which can accept up to six electrons to give the
corresponding amino derivative, aﬀects their biological activity. A useful review of ArNO 2 compounds related
to their toxicity, carcinogenicity, mutagenicity, therapeutic functions, and mechanism was reported by Kovacic
and Somanathan. 1 They stated that the mechanism is dependent on the electron transfer pathways of ArNO 2
compounds by the participation of nitroreductases, involving single-electron transfer leading to the formation
of nitroxyl anion radical (ArNO .−
2 ), nitroso (ArNO), hydroxylamine (ArNHOH), and amine (Ar-NH 2 ) derivatives. These species have a cytotoxic eﬀect on mammalian, protozoan, and bacterial cells. 1,22 Electrochemical
techniques, especially cyclic voltammetry (CV), are very useful tools for obtaining information on the physical
and chemical properties of electroactive molecules in organic electrochemistry. Electrochemical properties of
biologically important compounds can be very valuable for elucidation of the main redox reactions that occur in
the human body, providing a good approximation of what occurs in vivo. Therefore, electrochemical studies on
ArNO 2 compounds have garnered much interest in recent years due to their above discussed properties. 23−39 In
most of these studies, the electrochemical behavior of ArNO 2 compounds was explained by all nitro compounds
reducing in two cathodic processes giving hydroxylamine and amine derivatives via reduction by four electrons
and a further two electrons, respectively. It has also been reported that ArNO 2 compounds can generate a reversible single-electron process due to formation of ArNO .−
2 and an irreversible 3-electron process corresponding
to formation of ArNHOH. 24
In the current study, the electrochemical behaviors of six nitro-substituted benzamide compounds were
investigated by means of a pencil graphite electrode (PGE). When compared with other carbon-based electrodes,
PGEs have the same advantages, such as high electrochemical reactivity, commercial availability, good mechanical rigidity, disposability, low cost, low technology, and ease of modification. 40 In addition, it was reported
that pencil lead electrodes oﬀer a renewal surface that is simpler and faster than polishing procedures, common
with solid electrodes, and result in good reproducibility for individual surfaces. 40 Thus, many scientists have
recently focused on the use of this electrode in various electroanalytical applications due to the useful properties
of PGEs. 38−43 Accordingly, a PGE was chosen as the electrode material in this study due to its important
advantages including disposability, low cost, and renewable surface. 38−43 The eﬀect of pH and scan rate on the
reversible reduction oxidation of ArNO 2 to ArNO .−
2 and ArNHOH was investigated using CV. In addition,
to assess these ArNO 2 compounds as potential prodrug candidates in cancer therapy or biological activities,
diﬀerential pulse voltammetry (DPV) was also conducted.

2. Results and discussion
2.1. Cyclic voltammetric analysis of nitro benzamides
To investigate the electrochemical behavior of diﬀerent ArNO 2 amide compounds (1–6) (Figure 1), cyclic
voltammograms of each compound (with five repeated cycles) were recorded in Britton–Robinson buﬀer solution
(BRBS) (pH 7.0) containing 0.1 M KCl and 30% DMF at a scan rate of 50 mV s −1 at the PGE (Figure 2).
To elucidate the electrochemical mechanism, the potential was initially scanned from 0.1 to 0.8 V, then from
0.8 to –1.0 V, and finally from –1.0 to 0.1 V. Figures 2A–2F indicate that the electrochemical behaviors of
the substituted benzamides containing diﬀerent nitro groups show little diﬀerentiation from each other. For
example, cyclic voltammograms of 4-nitro- N -(phenyl)-benzamide (compound 1) are shown in Figure 2A. It has
three reduction peaks and Ic 1 (–600 mV), IIc 1 (–90 mV), and IIIc (–690 mV) (Figure 2A) can be attributed to
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the formation of one dihydroxylamine that immediately converted to hydroxylamine, the reduction of the nitroso
group to hydroxyl amine, and the formation of amine, respectively. The reason for this is that it has only one
NO 2 group. After the formation of dihydroxylamine (Ic 1 ), it immediately reduced to hydroxylamine since the
hydroxylamine was reduced at a more positive potential (about –90 mV). Finally, the produced hydroxylamine
reversibly oxidized to the nitroso group (IIa). On the other hand, the cyclic voltammogram of 4-nitro-N -(2nitrophenyl)benzamide (compound 2), containing two aromatic nitro groups, exhibits five reduction and three
oxidation peaks. In the first scanning range (from 0.1 to 0.8 V) of the first cycle, an irreversible peak attributed
to formation of radicals was not observed (Figure 2B). Peak potentials of all compounds are presented in Table
1. Cathodic peaks (IIc 1 and IIc 2 in Figure 2B), which appeared after the second cycle at about –70 and –130
mV, were not observed in the second scanning range (from 0.8 to –1.0 V) of the first cycle. In order to see
these peaks, first dihydroxylamines and then hydroxylamines must be produced. Thus, two irreversible peaks
were observed at –540 (Ic 1 ) and –625 (Ic 2 ) mV, in which two nitro groups were reduced to dihydroxylamine
by accepting four electrons/four protons.
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Figure 1. Structures of nitro aromatic compounds 1–6.

The current of these irreversible reduction peaks decreased with an increase in the scan cycle. This is
because the produced dihydroxylamines converted to a nitroso group by giving 2 mol of H 2 O for two dihydroxylamines, following which the produced nitroso group immediately reduced to monohydroxylamine, accepting
four electrons/four protons. In total, two -NO 2 groups in compound 2 were reduced to two monohydroxylamines by accepting eight electrons/eight protons. The produced monohydroxylamines converted to redox
pairs (IIa 1 /IIc 1 and IIa 2 /IIc 2 , Figure 2B) after the final scanning range (from –1.0 to 0.1 V), which can be
attributed to the N -phenylhydroxylamines being oxidized to the nitroso group by the two-electron/two-proton
process for one -NO 2 group (IIa 1 and IIa 2 , Figure 2B).
On the other hand, the final reduction process including irreversible reduction of ArNHOH to ArNH 2 by
accepting four electrons/four protons and giving 2 mol of H 2 O (Figure 3) was observed as overlapping/superimposed with dihydroxylamine peaks in the first scanning range. It can be seen that the formation of amines (IIIc,
Figure 2B) was observed to have more negative potential (–800 mV) than the formation of dihydroxylamines
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Figure 2. Cyclic voltammograms of 0.1 mM nitro benzamides (compounds 1 (A), 2 (B), 3 (C), 4 (D), 5 (E), and 6
(F)) for five successive cycles in BRBS (pH 7.0) containing 0.1 M KCl and 30% DMF. Red line is first cycle and other
colored lines are successive cycles. Black line: CV of supporting electrolyte in the absence of compounds.
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Table 1. Peak potentials of all reduction and oxidation peaks obtained from cyclic voltammograms of nitro benzamides
recorded at PGE in BRBS (pH 7.0) containing 0.1 M KCl and 30% DMF.

1
2

Peak potentials (mV)
Ic1
Ic2
Ic3
IIa1
–585
–75
–480 –580 15

3

–525

–655

0

4

–485

–655

0

5
6

–425
–500

–535

Compounds

–715
–645

IIa2

IIa3

IIc1
–95
–25

IIc2

IIc3

IIIa

–90

-

500 (small peak)

IIIc
–715
–735

–85

-

–70

–15

–65

-

–800

–70

–20

-110

420

–800

525
550

–835
–780

–5
10

–135

–65
–30

–155
–90

(–540 and –630 mV for Ic 1 and Ic 2 , respectively). In addition, an irreversible peak attributed to the formation
of one radical (IIIa, Figure 2B) was observed at 500 mV after the nitroso group was formed.
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Figure 3. Proposed mechanism for electrochemical behavior of compound 2.

These results can be interpreted by a mechanism proposed in the literature. 29,35 First, ArNO 2 groups
are irreversibly reduced to ArN(OH) 2 by four electrons/four protons for two nitro groups. Then the produced
ArN(OH) 2 groups convert to ArNO by giving 2 mol of H 2 O, which are immediately reduced to ArNHOH by
four electrons/four protons for two nitroso groups because the reduction potential of ArNHOH is more positive
than that of ArN(OH) 2 . Then ArNHOH is reversibly oxidized to ArNO by four electrons/four protons for two
nitro groups (Figure 3). Finally, the produced ArNHOH is also irreversibly reduced to ArNH 2 by accepting
four electrons/four protons and giving 2 mol of H 2 O (Figure 3).
Similar results were also obtained from the cyclic voltammograms of 4-nitro-N -(3-nitrophenyl)benzamide
(compound 3) (Figure 2C) and 4-nitro- N -(4-nitrophenyl)benzamide (compound 4) (Figure 2D). However, peaks
of Ic 1 , Ic 2 , and IIIc for these two benzamides (compounds 3 and 4) were observed separately, unlike the three
peaks observed as overlapping or superimposed for compound 2. In addition, IIa 1 /IIc 1 and IIa 2 /IIc 2 redox
pairs appeared separately for compounds 2 and 4, while they were observed as one peak for compound 3.
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SAĞLAM et al./Turk J Chem

Further experiments were also conducted on the benzamides including three nitro groups (compounds
5 and 6). Cyclic voltammograms of 4-nitro-N -(2,4-dinitrophenyl)benzamide (compound 5) and 4-nitro- N (3,5-dinitrophenyl)benzamide (compound 6) are shown in Figures 2E and 2F, respectively. Compound 5 has
four reduction peaks and the first three peaks (Ic 1 , Ic 2 , and Ic 3 ) are attributed to the formation of three
dihydroxylamines, representing three independent nitro groups on the molecule. The last peak (IIIc), which
overlapped with Ic 3 , represents the formation of ArNH 2 (Figure 2E). On the other hand, compound 6 has
three reduction peaks for the formation of three dihydroxyl amines, whereas it also has three independent nitro
groups (Figure 2F). As the nitro groups in the 3 and 5 positions of compound 6 have the same functions,
their reduction to dihydroxylamines appeared as two peaks. A peak at about –480 mV is attributed to the
combination of two reductions of nitro groups (Ic 1 + Ic 2 ) because the nitro groups in the 3 and 5 positions
have some properties. Another peak observed at –630 mV is attributed to the reduction of the last nitro group
(Ic 3 ) and the peak for the formation of ArNH 2 (IIIc) overlapped with this reduction peak. In addition, anodic
peak currents for the oxidation of hydroxylamines to nitroso groups (IIa 1 , IIa 2 , and IIa 3 ) were observed as one
peak, and the reduction of nitroso groups to hydroxylamines (IIc 1 , IIc 2 , and IIc 3 ) was observed as two peaks.
These results show that the structure of benzamides can aﬀect the electrochemical behavior of nitro groups.

2.2. Eﬀect of pH on electrochemical behavior of nitro benzamides
To investigate the eﬀect of pH on electrochemical responses (especially peak potential) of the nitro benzamide
compounds at the PGE, cyclic voltammograms of each compound were recorded in BRBS containing 0.1 M KCl
and 30% DMF at pH values ranging between 2.0 and 10.0 at a scan rate of 50 mV s −1 . Cyclic voltammograms
of each compound recorded at diﬀerent pH levels are shown in Supplementary Figures S1A, S1B, and S1C. The
dependence of the peak potentials of each compound on pH are also shown in Supplementary Figure S2. The
pH-potential curve of compound 1 (Supplementary Figure S2A) shows that peak potential decreases linearly
with the increasing of pH. Similar behavior was observed for all compounds. For example, the reduction (Ic 1 ,
Ic 2 , IIc 1 , and IIc 2 ) and oxidation (IIa 1 , IIa 2 , and IIIa) peak potentials for compound 2 (Supplementary Figure
S2B) shifted to negative values with an increase of pH from 2.0 to 10.0. Linearity changes were observed with
a slope of 40 mV for the reduction of Ic 1 and Ic 2 , and also a slope of about 55 mV/pH for the other reduction
(IIc 1 and IIc 2 ) and oxidation (IIa 1 , IIa 2 , and IIIa) peaks at pH values between 2.0 and 7.0.
However, it was observed that other dinitro compounds (compounds 3 and 4) have slightly diﬀerent
curves for all peaks compared to the curves of compound 2 (Supplementary Figures S2C and S2D). For example,
linearity ranges were observed at pH values between 2.0 and 6.0 and also a pH-potential curve was not obtained
for IIIa of compound 3 (and also compound 6) due to its disappearance in the cyclic voltammograms. pHpotential curves of the trinitro benzamide compounds are presented in Supplementary Figures S2E and S2F for
compounds 5 and 6, respectively. As can be seen, all peak potentials of these compounds shifted to negative
values when pH increased from 2.0 to 10.0. The reason for the shift of cathodic peak potentials toward more
negative values with increasing pH is that the nitro group accepted electrons more easily at low pH values
because protonation of the nitro group causes a decrease in electron density in the NO 2 group region. On the
other hand, electron transfer from the NO 2 group to the electrode for anodic peaks is easier at high pH values.
The linearity ranges of each oxidation and reduction peak were obtained from the pH-peak potential
curves. The equations for well-defined straight lines of each reduction and oxidation peak are summarized in
Table 2 for each compound. The peak potentials of reversible peaks (IIa 1 /IIc 1 , IIa 2 /IIc 2 , or IIa 1 + IIa 2 /IIc 1
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+ IIc 2 ), irreversible reduction peaks (Ic 1 and Ic 2 ), and the irreversible oxidation peak (IIIa) were pH-dependent
with a slope changing between –40 and –63 mV per pH (Table 2), which is close to the anticipated Nernstian
value of –59.16 mV. Therefore, it can be said that equal numbers of electrons and protons are transferred in the
electrochemical reduction of Ar-NO 2 to Ar-N(OH) 2 (2e − /2H + for one NO 2 group), oxidation of the produced
Ar-NHOH to Ar-NO (2e − /2H + for one NO 2 group), and also irreversible reduction of Ar-NO to Ar-NHO •−
(1e − /1H + for one NO 2 group).
Table 2. Equations of peaks obtained from linear plot of pH versus potential of compounds 1–6.
Compound 1

Compound 2

Compound 3

Compound 4

Compound 5

Compound 6

Peak
pH 2–7

pH 2–6

Ic1

y = –53x – 174
R2 = 0.9819

y = –40x – 258
R2 = 0.9951

y = –41x – 297
R2 = 0.9906

y = –49x – 230
R2 = 0.9934

y = –43x – 131
R2 = 0.9988

y = –52x – 199
R2 = 0.9957

Ic2

-

y = –40x – 347
R2 = 0.9988

y = –46x – 351
R2 = 0.9911

y = –51x – 372
R2 = 0.9915

y = –58x – 152
R2 = 0.9773

y = –59x – 312
R2 = 0.9996

Ic3

-

-

-

-

y = –85x – 182
R2 = 0.9708

-

IIa1

y = –63x + 419
R2 = 0.9946

y = –56x + 342
R2 = 0.9951

IIa2

-

y = –56x + 268
R2 = 0.9956

y = –55x + 343
R2 = 0.9957

y = –56x + 349
R2 = 0.9940

IIa3

-

-

IIc1

y = –60x + 375
R2 = 0.9906

y = –56x + 316
R2 = 0.9933

IIc2

-

y = –54x + 250
R2 = 0.9933

y = –55x + 343
R2 = 0.9957

y = –60x + 339
R2 = 0.9953

IIc3

-

-

-

-

y = –58x + 323
R2 = 0.9950

-

IIIa

-

y = –49x + 758
R2 = 0.9901

-

y = –46x + 715
R2 = 0.9939

y = –63x + 760
R2 = 0.9927

-

y = –57x + 345
R2 = 0.9985

y = –59x + 353
R2 = 0.9928
y = –57x + 236
R2 = 0.9972

y = –60x + 318
R2 = 0.9964

y = –58x + 334
R2 = 0.9908
y = –60x + 246
R2 = 0.9926

However, the peak potential of the irreversible reduction peaks (Ic 3 ) for compound 5 was pH-dependent
with a slope of –85 mV per pH, indicating that the peak for the formation of Ar-NH 2 may aﬀect this peak.
The peak for the reduction of ArNHOH to ArNH 2 was not evaluated due to its instability. The pH experiment
showed a general trend of decreasing reduction and oxidation peak potentials as the pH increased, indicating
the involvement of hydronium ions in the whole reduction and oxidation process toward nitro-substituted
benzamides.
2.3. Eﬀect of scan rate on electrochemical behavior of nitro benzamides
In order to observe the eﬀect of scan rate on peak currents of the nitro benzamides, cyclic voltammograms of
compound 3 were selected (0.1 M BRBS at pH 7.0 containing 30% DMF and 0.1 M KCl) and were recorded
at various scan rates using the PGE. The cyclic voltammograms for the first and second cycles of compound 3
dependent on scan rate are shown in Supplementary Figure S3. These cyclic voltammograms demonstrate that
the oxidation peak potential of ArNHOH to Ar(N=O) (IIa 1 + IIa 2 ) shifts in a positive direction, while the
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reduction peaks attributed to the formation of ArN(OH) 2 (Ic 1 and Ic 2 ) and ArNHOH (IIc 1 + IIc 2 ) shift in
a somewhat negative direction with an increase of scan rate, indicating the kinetic limitations of the reduced
process. The peak currents of IIa 1 + IIa 2 , IIc 1 + IIc 2 , Ic 1 , and Ic 2 dependent scan rates were calculated
from the second cycle. With an increase of scan rate, all peak currents varied linearly as the square root of the
scan rate (Figure 4). These results manifested a typical diﬀusion-controlled electrochemical process. Similar
behavior was also obtained for the other nitro compounds.

Figure 4. Plot of peak currents of compound 3 versus square root of scan rate.

2.4. Diﬀerential pulse voltammetric determination of nitro benzamides
In order to verify the practical applicability of the voltammetric determination of compounds 1–6, compound 2
was selected as a model nitro benzamide for the monitoring of its diﬀerential pulse (DP) voltammogram. The
influence of pH on the DP voltammetric behavior of 1.0 mM compound 2 at the PGE was investigated in BRBS
containing 0.1 M KCl and 30% DMF at pH values ranging between 2.0 and 9.0. To observe the oxidation of
the produced ArNHOH to Ar-NO with 4e − (for two nitro groups), its DP voltammograms were recorded in
the potential range of –500 mV to 500 mV. It can be seen from Figure 5A that compound 2 gives two anodic
peaks, corresponding to the oxidation of ArNHOH to the ArNO group over the whole pH region. Figure 5B
shows that the highest peak current was obtained at pH 7.0. Therefore, BRBS with pH 7.0 containing 0.1 M
KCl and 30% DMF was used as the supporting electrolyte for subsequent DP voltammetric experiments.
To examine the relationship between anodic peak current corresponding to the oxidation of ArNHOH to
the ArNO group, DP voltammograms of compound 2 were recorded in BRBS (pH 7.0) containing 0.1 M KCl
and 30% DMF. Figure 6 shows the DP voltammograms at the PGE for various concentrations of compound 2.
A linear response was observed in the range between 0.5 and 100 µ M (y (µ A cm −2 ) = 1.7x ( µM) + 15.9, R 2
= 0.9901) (Figure 6, inset). The limit of detection (LOD) and limit of quantification (LOQ) were calculated by
evaluation of the peak current for the smallest observable concentration of compound 2. LOD and LOQ values
were found to be 0.16 µ M and 0.52 µ M, respectively, using the equations of LOD = 3Sb / m and LOQ = 10Sb
/ m , where Sb is the standard deviation of the concentration of compound 2 (0.1 µ M) and mis the slope of
the calibration plot (1.7 µ A µ M −1 cm −2 ).
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Figure 5. A) Diﬀerential pulse voltammograms of 5.0 µ M compound 2 in BRBS with diﬀerent pH values containing
0.1 M KCl and 30% DMF (pulse amplitude: 20 mV, pulse time: 30 s, scan rate: 25 mV s −1 ) . B) Plot of peak current
of compound 2 versus pH.

Figure 6. A) Diﬀerential pulse voltammograms of compound 2 at PGE in BRBS (pH 7.0) containing 0.1 M KCl and
30% DMF for diﬀerent concentrations of compound 2 (pulse amplitude: 20 mV, pulse time: 30 s, scan rate: 25 mV
s −1 ) . B) Plot of peak current of compound 2 versus concentration. Inset: Calibration curve for compound 2.

The proposed electrode was used for the determination of compound 2, which was selected as a model
compound in spiked urine and also artificial prepared blood serum samples. Artificial blood serum samples
were prepared according to the literature 44 without including compound 2. For this, DP voltammograms were
recorded by spiking a known volume and concentration of compound 2 standard solutions into the urine and
artificial blood serum samples to obtain various concentrations. The obtained recovery results (Table 3) show
that acceptable recoveries were obtained for spiked compound 2 in urine and artificial blood serum samples.
These results indicate that nitro benzamide drugs can be successfully determined in pharmaceutical samples.
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Table 3. The results of recovery studies for determination of compound 2 in urine and artificial blood serum samples
(n = 3).

Sample
Urine

Artificial blood serum

Added / µM
0
15.0
30.0
0
15.0
30.0

Found / µM
0
14.5 ± 0.8
30.2 ± 1.2
0
15.4 ± 0.3
30.3 ± 1.1

Recovery %
96.7
100.7
102.7
101.0

The sensitivity and linearity ranges of the proposed method were compared with other bare or modified
electrodes in previously published reports for electrochemical detection of aromatic nitro compounds (Table 4).
The sensitivity and linearity range of the proposed method for determination of compound 2 was found to be
1.7 µ A cm −2 L µ mol −1 and 0.5–100 µ M, respectively. As can be seen in Table 4, the linearity range is wider
than that for the DP voltammetric determination of nitrofurantoin (NF) at a mercury meniscus modified silver
solid amalgam electrode (2–100 µ M), 36 determination of 2-amino-6-nitrobenzothiazole (ANBT) at a silver solid
amalgam electrode modified by a microcrystalline natural graphite polystyrene composite film (0.2–10 µ M), 33
amperometric detection of nitrophenol (NP) at a porous copper modified PGE (50–850 µ M), 38 and cyclic
voltammetric determination of trinitrotoluene (TNT) (2.5–40 and 40–120 mg L −1 ) and dinitrotoluene (DNT)
(2–40 and 40–140 mg L −1 ) . 30,31 The sensitivity of the proposed method is higher than that of determination of
NF, 36 ANBT and 5-nitrobenzimidazole (5-NBIA), 33 NP, 38 TNT, and DNT. 30,31 Moreover, it is comparable
to that obtained with determination of niclosamide at a PGE 39 and determination of aromatic nitro compounds
(nitrobenzene, TNT, and DNT) at a Pd nanoparticle graphene modified GCE. 34
Therefore, it can be said that PGE is very useful electrode material for investigation of the electrochemical
behavior of aromatic nitro compounds, and also their determination, due to PGE having important advantages
in terms of high electrochemical reactivity, commercial availability, good mechanical rigidity, disposability, low
cost, low technology, ease of modification, lack of need for polishing, and a renewable surface.
In conclusion, an investigation on the electrochemical behavior of several nitro benzamides, prodrug
candidates for nitroreductase-based cancer therapy, was presented in this study. The reduction and oxidation
processes for all compounds changed depending on the pH of the experimental setups. Peak potential of
all peaks decreased with increasing pH, with a slope near the anticipated Nernstian value of –59.16 mV.
Therefore, it can be said that equal numbers of electrons and protons are transferred in all the electrochemical
reduction and oxidation processes. We successfully created an extremely low-cost, disposable, and practical
nitro benzamide sensor to record their DP voltammograms. This result indicates that nitro benzamides in
drugs or pharmaceutical samples can easily be determined by the DP voltammetric procedure.

3. Experimental
3.1. Apparatus and chemicals
All electrochemical experiments were carried out using a CompactStat Electrochemical Interface (Ivium Technologies, Eindhoven, the Netherlands). Cyclic and DP voltammetric experiments were carried out in a 10-mL
789
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Table 4. Comparison of analytical parameters of compound 2 at PGE with some electrodes in the literature for
electrochemical detection of various aromatic nitro compounds.
Used modified electrode

Pretreated GCE

790

Methodology

CV in MeCN
including 0.04 M
Bu4NBr

Compound

LR

LOD / LOQ

Ref.

1,3,5-Trinitro1,3,5-triaza
cyclohexane
(RDX)

30.0–120.0 mg L–1

10.2 / 20.6 mg L–1

Octahydro-1,3,5,7tetranitro-1,3,5,7tetrazocine
(HMX)

40.0–120.0 mg L–1

11.7 / 29.6 mg L–1

Trinitrotoluene
(TNT)

40.0–120.0 mg L–1

11.2 / 23.0 mg L–1

Dinitrotoluene
(DNT)

40.0–140.0 mg L–1

10.8 / 26.7 mg L–1

TNT

2.5–40.0 mg L–1

2.1 / 7.0 mg L–1

DNT

2.0–40.0 mg L–1

1.3 / 4.0 mg L–1

30

Gold nanoparticles/poly
(o-phenylene diamineaniline) film modified
glassy carbon electrode

CV in MeCN:H2O
(5:95%) including
0.04 M NaCl

A silver solid amalgam
electrode modified by a
microcrystalline natural
graphite–polystyrene
composite film

Direct current
voltammetry (DCV)
and differential
pulse voltammetry
in
a) MeOH-BR buffer
pH 4.0 (1:9) for
ANBT,
b) MeOH-BR buffer
pH 7.0 (1:9) for 5NBIA

Pd nanoparticles on
functionalized graphene
modified GCE

DPV in 0.2 M PBS
and 0. 5 M NaCl

Nitrobenzene

1.0–170.0 ppb

0.62 ppb / -

34

Mercury meniscus
modified silver solid
amalgam electrode

DCV and
differential pulse
voltammetry in
methanol-BR buffer
pH 7.0 (1:9)

Nitrofurantoin

DCV: 6.0–100.0 µM
DPV: 0.2–100.0 µM

DCV: - / 1.6 µM
DPV: - / 0.081 µM

36

Porous copper-modified
graphite pencil electrode

Amperometric
detection in pH 4.8
acetate buffer
solution at –500 mV

4-Nitrophenol

50.0–850.0 µM

1.91 µM / -

38

Pencil graphite electrode

DPV in pH 7.0 BR
buffer solution
containing 0.1 M
KCl and 30% DMF

Niclosamide

0.05–10.0 µM

0.015 µM / -

39

Pencil graphite electrode

DPV in pH 7.0 BR
buffer solution
containing 0.1 M
KCl and 30% DMF

4-Nitro-N-(2nitrophenyl)benza
mide as a model
compound

0.5–100.0 µM

0.16 / 0.52 µM

This
work

Tetryl
2-Amino-6nitrobenzo
thiazole (ANBT)

5-Nitrobenz
imidazole
(5-NBIA)

5.0–100.0 mg L

–1

0.2–10.0 µM

0.2–10.0 µM

3.8 / 12.6 mg L

31

–1

Reduction
DCV: - / 0.89 µM
DPV: - / 0.77 µM

Reduction
DCV: - / 0.62 µM
DPV: - / 0.31 µM

33
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voltammetric cell at room temperature (25 ◦ C) using the traditional three-electrode system. A platinum wire,
an Ag/AgCl/KCl sat , and a PGE were used as the counter, reference, and working electrodes, respectively.
The properties of the PGE were described in our previous work. 39 The 2B pencil graphite was obtained from
Tombow (Japan) and consisted of 74% graphite and 20% clay. Its electrical resistance was measured and found
to be about 0.5 ohm cm −1 . It oﬀers very little electrical resistance, which does not produce a significant ohmic
drop in the CV responses. This indicates that the PGE is a good candidate for electrode material. For each
measurement, a total of 10 mm of lead (active electrode area was calculated as 0.159 cm 2 ) was immersed into
the solution. An HI 221 Hanna pH meter with a combined glass electrode (Hanna HI 1332) was used to follow
the pH values of the solutions. All solutions were prepared with ultrapure water from an Elga Option Q7B
water purification system (18.2 MΩ cm).
4-Nitrobenzoyl chloride (98%), nitro-substituted anilines, magnesium sulfate (≥99.5%), sodium carbonate ( ≥99.0%), triethylamine and pyridine (for HPLC purity, ≥99.5%), benzene (for HPLC purity, ≥ 99.9%),
H 3 PO 4 (85%, d: 1.71 g mL −1 ), CH 3 COOH (96%, d: 1.05 g mL −1 ) , H 3 BO 3 , NaOH, and KCl were purchased
from Sigma-Aldrich and all solvents were supplied by Merck. Dimethyl formamide (DMF) was purchased from
Sigma (USA). BRBS in the pH range of 2–10 was prepared from 0.04 M H 3 PO 4 , 0.04 M H 3 BO 3 , and 0.04 M
CH 3 COOH containing 0.1 M KCl in deionized water. The pH of the solutions was adjusted by adding 0.2 M
NaOH containing 0.1 M KCl.
3.2. Synthesis of nitro-substituted benzamide compounds
Six diﬀerent nitro benzamide compounds, 4-nitro-N -(phenyl)-benzamide (1), 4-nitro-N -(2-nitrophenyl)benzamide (2), 4-nitro- N -(3-nitrophenyl)benzamide (3), 4-nitro- N -(4-nitrophenyl)benzamide (4), 4-nitro- N -(2,4dinitrophenyl)benzamide (5), and 4-nitro-N -(3,5-dinitrophenyl)benzamide (6), were synthesized according to
the literature 45−49 with some modifications and their structures were confirmed with 1 H NMR and
The purity of compounds was determined according to NMR data.

13

C NMR.

3.3. Electrochemical procedure
The electrochemical behavior of the ArNO 2 compounds (1–6) was investigated by recording their cyclic
voltammograms at the PGE in BRBS in the pH range of 2.0–10.0 containing 30% DMF and 0.1 M KCl.
We placed 10 mL of supporting electrolyte containing 30% DMF and 0.1 M KCl in the electrochemical cell and
10 mm of pencil graphite was immersed into the supporting electrolyte. Cyclic voltammograms were recorded
at a scan rate of 50 mV s −1 using a potential applied profile with two stop crossing, in which the potential
was initially scanned from 0.1 V to 0.8 V, then from 0.8 V to –1.0 V, and finally from –1.0 to 0.1 V. Then
the cyclic voltammograms of the PGE were recorded in the presence of 1.0 × 10 −4 M ArNO 2 under the same
experimental conditions after the required volume of 0.01 M stock solution of ArNO 2 was added to the cell.
Cyclic voltammograms of each ArNO 2 were also recorded at various scan rates. High purity argon was used to
purge the supporting electrolyte for 5 min before all electrochemical experiments.
Following this, the DP voltammetric technique was used for determination of ArNO 2 compounds, as in
several biological and medical applications. First, the eﬀect of pH on the DP voltammograms of each 2.5 ×
10 −5 M ArNO 2 compound was investigated. DP voltammograms were recorded in a potential range between
–0.8 V and 0.4 V at a scan rate of 25 mV s −1 and using optimized pulse amplitude (20 mV) and pulse time
(30 ms). After each successive DP voltammetric measurement, argon gas purged the supporting electrolyte for
20 s prior to the next measurement.
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DP voltammetric determination of compound 2 was performed in two diﬀerent samples, urine and
artificial blood serum, which were prepared according to literature 44 . Urine samples were obtained from a
healthy volunteer and filtered with a membrane filter. Spiked samples were prepared by mixing the proper
amount of sample solutions with a known concentration of compound 2. Then DP voltammograms were
recorded for each sample under conditions described in Figure 6.
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Supplementary data
Electrochemical behavior and voltammetric determination of some nitro-substituted benzamide
compounds

Figure S1A. Cyclic voltammograms of 0.1 mM mononitro benzamide for five successive cycles in BRBS (pH of 2, 5,
and 9) containing 0.1 M KCl and 30% DMF (compound 1).
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Figure S1B. Cyclic voltammograms of 0.1 mM dinitro benzamides for five successive cycles in BRBS (pH of 2, 5, and
9) containing 0.1 M KCl and 30% DMF (compounds 2, 3, and 4).
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Figure S1C. Cyclic voltammograms of 0.1 mM trinitro benzamides for five successive cycles in BRBS (pH of 2, 5, and
9) containing 0.1 M KCl and 30% DMF (compounds 5 and 6).
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Figure S2. Plot of peak potentials of each nitro benzamide (compounds 1 (A), 2 (B), 3 (C), 4 (D), 5 (E), and 6 (F))
versus pH.
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Figure S3. Cyclic voltammograms of compound 3 at diﬀerent scan rates in BRBS (pH 7.0) containing 0.1 M KCl and
30% DMF on PGE.
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